23 results
424B5
NLSP
NLS Pharmaceutics Ltd
22 Mar 24
Prospectus supplement for primary offering
10:24am
circumstances, minority shareholders of the corporation being acquired may be compensated in a form other than through shares of the acquiring
424B5
NLSP
NLS Pharmaceutics Ltd
14 Apr 22
Prospectus supplement for primary offering
4:48pm
% of the outstanding shares. In these limited circumstances, minority shareholders of the corporation being acquired may be compensated in a form other than
424B5
49jo8
4 Mar 22
Prospectus supplement for primary offering
4:01pm
F-3
uxx05vt
3 Feb 22
Shelf registration (foreign)
4:00pm
F-1
jwjsce4 b7adc8
20 Dec 21
Registration statement (foreign)
4:06pm
F-1/A
auy0ho049qn
1 Nov 21
Registration statement (foreign) (amended)
8:30am
F-1
f3mgp2ig3zl
22 Oct 21
Registration statement (foreign)
4:02pm
POS AM
ejfcnyi1jttcss
30 Sep 21
Prospectus update (post-effective amendment)
4:00pm
POS AM
lgqmwcfpskgk nx
27 May 21
Prospectus update (post-effective amendment)
5:28pm
20-F
EX-2.1
0mqddznp9fu1i3g a6x
14 May 21
Annual report (foreign)
5:05pm
20-F
qv9uxqg6qt4s ilofc7n
14 May 21
Annual report (foreign)
5:05pm
424B4
f5e5r 60km
1 Feb 21
Prospectus supplement with pricing info
11:52am
F-1/A
qdk1yr727np1ljsu68e
20 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1/A
p52jrwslgookm07o8tb9
17 Nov 20
Registration statement (foreign) (amended)
5:28pm
F-1/A
zgqva146iw eva8
16 Oct 20
Registration statement (foreign) (amended)
9:59pm
F-1/A
9n7l424mt iglsj8we
31 Aug 20
Registration statement (foreign) (amended)
9:26am